Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-004667
Filing Date
2012-03-08
Accepted
2012-03-08 20:24:03
Documents
1
Period of Report
2012-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3929
  Complete submission text file 0001179110-12-004667.txt   5110
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Rieder Wendy E (Reporting) CIK: 0001325714 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 12678746